Iron deficiency syndromes in clinical oncology and their correction with nutritive action drugs
https://doi.org/10.33667/2078-5631-2019-2-13(388)-20-25
Abstract
Treatment of iron deficiency conditions by nutritive support media is one of the debatable areas. In the analysis of nutritional status, nutritional risk and ferrumdeficiency parameters in patients with operated colorectal cancer in different stages, the possibility of correction of prelatent and latent iron deficiency with ferrum‑containing media of nutritional alimentation is shown. With the development of anemia, the use of с intravenous correction (preferably with drugs sorbed on a special matrix that allows the gland to be isolated in portions) is shown.
About the Authors
L. N. Kostyuchenko
Moscow Clinical Scientific Centre
Russian Federation
Moscow
Russian Federation
Moscow
G. S. Mikhailyantz
Moscow Clinical Scientific Centre
Russian Federation
Moscow
Russian Federation
Moscow
M. Y. Danilov
Moscow Clinical Scientific Centre
Russian Federation
Moscow
Russian Federation
Moscow
A. O. Atroshchenko
Moscow Clinical Scientific Centre
Russian Federation
Moscow
Russian Federation
Moscow
A. D. Kruglov
Moscow Clinical Scientific Centre
Russian Federation
Moscow
Russian Federation
Moscow
K. K. Noskova
Moscow Clinical Scientific Centre
Russian Federation
Moscow
Russian Federation
Moscow
A. E. Lychkova
Moscow Clinical Scientific Centre
Russian Federation
Moscow
Russian Federation
Moscow
M. V. Kostyuchenko
Russian National Research Medical University n.a. N.I. Pirogov
Russian Federation
Moscow
Russian Federation
Moscow
References
1. Анемии / Под ред. О. А. Рукавицына. — М., 2018. — 165 с.
2. Нурициология в онкологии пищеварительного тракта // Под ред. Л. Н. Костюченко. — М., 2019. — 346 с.
3. Рак толстой кишки // Под ред. Дж. Мейерхардта, М. Сандерза. — М., 2009. — 183 с.
4. В. Дж. Маршалл. Клиническая биохимия. — М., 2015. — С. 343–346.
5. Руководство по химиотерапии опухолевых заболеваний // Под ред. Н. И. Переводчиковой, В. А. Горбуноц. — М., 2018. — М. 208–223.
6. Злокачественные опухоли. Практические рекомендации Российского общества клинической онкологии. — М. 2018. — С. 494–502 и 289–325.
7. Снеговой А. В., Аарго М. и др. Злокачественные опухоли. — 2016. — № 4. — С. 368–377.
8. Bregman D. et al. Hepcidin levels predict non-responsiveness to oral iron therapy in patients with iron deficiency anaemia. Am J Hematol 2013 Feb; 88 (2): 97–10.
9. Weigang-Kohler K., Vetter A., Thyroff-Friesinger U. HX575, recombinant human epoetin alfa, for the treatment of chemotherapy-associated symptomatic anaemia in patients with solid tumors. — Oncology, 2009; 32 (4): 168–174.
Review
For citations:
Kostyuchenko L.N., Mikhailyantz G.S., Danilov M.Y., Atroshchenko A.O., Kruglov A.D., Noskova K.K., Lychkova A.E., Kostyuchenko M.V. Iron deficiency syndromes in clinical oncology and their correction with nutritive action drugs. Medical alphabet. 2019;2(13):20-25. (In Russ.) https://doi.org/10.33667/2078-5631-2019-2-13(388)-20-25
Views:
282
Email this article 